News
Topline interim dataset from GALAXIES Lung-201 with >240 patients anticipated in 2Q25 - Interim datasets from GALAXIES H&N-202 and TIG-006 HNSCC with ~200 patients anticipated in 2025 - Cash ...
Phase 1 dose-escalation study to evaluate ziftomenib in combination with imatinib in patients with advanced GIST after imatinib failure - - Combination of ziftomenib and imatinib shows robust and dura ...
CERo Therapeutics has announced that Colorado Blood Cancer Institute’s (CBCI) Sarah Cannon Research Institute (SCRI), US, will be the main site for its Phase I study evaluating CER-1236 to treat acute ...
The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...
In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...
Zacks Investment Research on MSN18d
PHIO Stock Soars as Safety Panel Clears Skin Cancer Drug for Next DoseShares of Phio Pharmaceuticals PHIO rallied 52.5% on Wednesday after the company announced that the Safety Monitoring Committee (SMC) has recommended dose escalation in an early-stage study of the ...
The pace of that escalation has been stunning. Over the course of a week, Trump’s tariffs on Chinese imports have jumped from 54% to 104% and now 125% – figures that add to existing levies ...
Trump says he's planning more tariffs on April 2, calling it "Liberation Day." Here's what it means.
Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 ...
China will impose additional 50 per cent tariffs on all American imports in response to a similar level of tariff increases on its goods from US President Donald Trump, marking what threatens to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback